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Abstract—This project presents the development of an 
analysis system via simulation approach of glucose-insulin 
dynamics in a virtual Type 1 Diabetes Mellitus (T1DM) patient: 
Hovorka diabetic model using MATLAB Graphical User 
Interface (GUI). This analysis system is developed for a 
convenient technique in studying the interaction of insulin on 
blood glucose level based on meal and insulin taken. Several 
simulations of glucose-insulin dynamics have been conducted 
using the developed system to study the effect of patient body 
weight, a number of meal intake and amount and timing of 
insulin injection to the changes of blood glucose concentration. 
 
Index Terms—Glucose-insulin Dynamics; Mathematical 




A survey conducted by the Institute for Public Health 
Malaysia in 2015 shows that there were 17.5% of Malaysian 
adults range from 18 years old and above suffering diabetes 
with 8.3% were known to have diabetes while 8.0% were 
undiagnosed with diabetes [1]. In addition, every ten seconds, 
two persons in the world develop diabetes and a person dies 
from diabetes [2]. 
Generally, diabetes can be categorized into two; Type 1 
Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus 
(T2DM). The T1DM results from an absolute lack of insulin 
production in the pancreas that required insulin replacement 
therapy whereas, the T2DM results from insufficient insulin 
secretion from the pancreas or insulin resistance increment in 
the body that is basically not required insulin injection [3]. 
The management of T1DM requires a lot of concern to 
various aspects such as insulin administration, blood glucose 
monitoring, balancing food intake and diabetes-related 
complications [4]. The goal of T1DM care is to regulate the 
blood glucose concentration within a normoglycemic range 
between 4 and 8 millimoles per liter (mmol/L) [5] in order to 
avoid the risks of hyperglycemia (high blood glucose 
concentration) and hypoglycemia (low blood glucose 
concentration) through exogenous insulin administration. 
When a patient accidentally is injected with too much insulin, 
the blood glucose concentration will be highly reduced. This 
leads to abnormally low blood glucose levels (hypoglycemia) 
which particularly affects the brain and causes symptoms 
such as dizziness, confusion and even coma in severe cases 
[6]. Thus, the injection of the insulin with respect to the 
present blood glucose concentration must be very accurate 
because any miscalculation of insulin dosage will bring about 
severe problems. 
Recently, a comprehensive mathematical modeling 
managed via in-silico simulation is useful and preferably 
performed in helping researchers in enhancing the knowledge 
on the glucose-insulin dynamic system rather than evaluation 
and testing of medical treatment delivery in humans which 
are inordinate, exorbitant and confounded by ethical issues 
[7]. There are a number of mathematical models available in 
modeling the glucose-insulin system such as linear dynamic 
models [18], glucose-insulin compartmental models [8,9] and 
progressed to large-scale in-silico experiments through non-
linear model predictive control [10] and artificial intelligence 
(AI) tools [11]  and automated closed-loop control (artificial 
pancreas) for insulin prediction and glucose control [12]. 
Therefore, in this study, a model simulation based analysis 
system for blood glucose-insulin interaction based on the 
Hovorka diabetic model [11] for T1DM will be developed 
using GUI MATLAB towards a convenient use in studying 
the interaction between the insulin and the blood glucose 
based on body weight, number of meal intake and the amount 
of insulin injected. 
The paper is outlined as follows. The methodology of the 
overall process in developing the simulation-based analysis 
system of glucose-insulin dynamics in T1DM is stated in 
Section II. While in Section III, the results together with the 
discussions are presented. Finally, the concluding remarks 




In this research, the GUI for the analysis of glucose-insulin 
dynamics based on the Hovorka diabetic model has been 
designed using MATLAB software. Moreover, the Hovorka 
model which is represented by nonlinear Ordinary 
Differential Equations (ODEs) is basically solved using 
MATLAB ODE solver function of ode23 with the relative 
tolerance setting of 1e-6. 
 
A. Hovorka Diabetic Model 
Hovorka model used in this study has ten nonlinear 
ordinary differential equations (ODEs) which include three 
subsystems; carbohydrate (CHO) absorption system, 
subcutaneous insulin absorption system and gluco-regulatory 
system. It accurately represents patients with type 1 diabetes 
[13]. Figure 1 illustrates the block diagram of the model, 
where the UG and UI are time-dependent inputs representing 
CHO absorption and insulin absorption, respectively. The 
model will be producing two outputs; glucose concentration, 
G(t) and plasma insulin concentration, I(t). In this project, we 
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are focusing on the glucose concentration level as the output 
from the system. The equations involved in each of the 
subsystems can be referred in the previous works [11, 14]. 
Where, 
 
D1 : Amount of glucose in compartment 1, stomach 
[mmol] 
D2 : Amount of glucose in compartment 2, colon 
[mmol] 
UG : Glucose absorption rate [mmol/min] 
S1 : Amount of insulin in compartment 1, stomach 
[mU] 
S2 : Amount of insulin in compartment 2, colon 
[mU] 
UI : Insulin absorption rate into the bloodstream 
[mU/min] 
Q1 : Amount of glucose in the bloodstream [mmol] 
Q2 : Amount of glucose in the peripheral tissue 
[mmol] 
G(t) : Blood glucose concentration [mmol/L] 
x1 : Insulin dependent state: transport and 
distribution 
x2 : Insulin dependent state: glucose disposal 
x3 : Insulin dependent state: endogenous production 
of glucose 





















Figure 1: Block diagram of Hovorka diabetic model representation [15] 
 
B. System Operation of the GUI for the Analysis of 
Glucose-Insulin Dynamics 
Figure 2 illustrates the block diagram of the GUI system 
for simulation-based glucose-insulin analysis system. This 
simulation begins with by key in process of patient data 
which are the body weight of a patient, the time to consume 
each meal and insulin administration consume per day and 
the amount of CHO and the insulin intake to the simulation 
program. Next, the results from the simulation have analyzed 




Figure 2: Flow of the GUI analysis system of glucose-insulin dynamics 
 
III. RESULTS AND DISCUSSION 
 
A. GUI Analysis System of Glucose-Insulin Dynamics 
Figure 3 shows the constructed GUI for the analysis of 
glucose-insulin dynamics based on the Hovorka diabetic 
model. This GUI analysis system is able to perform several 
simulation tests related to the glucose-insulin dynamics in a 
convenient way by comprehensively input related 
parameters. In order to simulate the glucose concentration, 
the GUI system needs the data from a user to key in into the 
system. The data include the type 1 diabetes patient’s body 
weight (BW), the time of meal taken (Meal Time [24-hour 
system]), the amount of meal taken (CHO Rate in Bolus 
Size), the time of insulin injection (Insulin Time[24-hour 
system]) and the amount of insulin dose (Insulin Rate in 
Bolus Size). 
 
B. Analysis Studies using the GUI 
The performance of the developed GUI system is evaluated 
by conducting analysis on the glucose-insulin dynamics. In 
this paper, the results presented are based on the analysis of 
the amount of insulin, the insulin intake time and the 
bodyweight influences on the BGC with a five-time meal 
disturbance to represent a full course of meals per day; 
breakfast, lunch, tea-time, dinner and supper. 
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Figure 3: Graphical User Interface (GUI) for the analysis of glucose-insulin dynamics based on the Hovorka diabetic model 
 
C. Effect of the Insulin Administration on the BGC 
A hormone that helps to regulate the blood glucose 
concentration is the insulin secreted by the β-cell of the 
pancreatic islets of the pancreas. The malfunction of the 
pancreas to produce an adequate amount of insulin can cause 
hyperglycemia state. This simulation has been done to 
analyze the effect of the insulin on the blood glucose 
concentration, by using five meal intakes per day in a bolus 
size input. The amount of CHO rate and insulin rate used for 
the simulation are based on the data from the previous work 
[16] and summarized in Table 1. 
 
Table 1 
The Summary of the CHO and Insulin Input Data of The GUI System 












in bolus size 
(mU/min) 
09:30 24.84 09:30 700 
12:30 7.32 12:30 250 
16:00 6.9 16:00 200 
18:45 15.4 18:45 490 
21:00 6.9 21:00 210 
 
The simulation has been carried out according to two 
conditions. The first condition used only a basal insulin 
infusion rate input, Ubasal at 5.06 mU/min with no 
administration of insulin and it is calculated according to the 
normoglycemia at 5 mmol/L. While the second condition is 
using an insulin infusion rate of a bolus size input added at 
the same time as each meal as in Table 1. 
Figure 4 shows the superimposed graphs of the BGC 
dynamics changes in the 24-hour simulation according to the 
two conditions mentioned above. From the figure, it is found 
that the BGC with insulin intake is much lower and stable 
compared to the glucose concentration with the basal insulin 
only which causes the hyperglycemia since the insulin intake 
helps to regulate the blood glucose from hyperglycemia state 
into the normal state. The pattern of graph showed in [16] also 
emphasized the importance of insulin intake when the patient 
is suffering from diabetes. If no insulin is administered, the 
patient blood glucose will be high throughout a day and may 
lead to serious complications. 
 
 
Figure 4: Comparison between the BGC with the basal insulin only and the 
BGC with the insulin bolus for the virtual diabetic patient bodyweight of 53 
kg 
 
D. Effect of the Insulin Intake Time to the BGC 
In this simulation, the insulin intake time has been varied 
between five minutes until 30 minutes before and after meal 
consumed. Besides, a few meal has been set to five meals per 
day and the input value for the insulin intake dose and CHO 
are referred to the previous research in [17] as shown in Table 
2. Figure 5 shows the GUI during the simulation of the BGC 
when the insulin injection time is 30 minutes before each of 
the meals. Meantime, Figure 6 shows the superimposed graph 
of the BGC results based on the insulin injection time varies 
every five minutes from 5 to 30 minutes before and after each 
of the meal. From the results, it can be understood that the 
BGC control is much better when the insulin is taken before 
the meal compared to after the meal since for the 
subcutaneous insulin injection, the insulin absorption time is 
larger than the meal absorption time. The longer the insulin 
intake time before having the meal, the better the BGC level 
can be controlled. This is because the insulin is administered 
into the patient body will take time to get effective to respond 
to any changes in the blood glucose level [19]. However, 
according to the analysis conducted, the insulin intake time 
before having a meal is longer than 30 minutes will cause the 
insulin to react too early and affects the BGC level to 
hypoglycemia.  
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Table 2 










Insulin rate in 
bolus size 
(mU/min) 
09:30 17.4 09:00 650 
12:30 31.54 12:00 900 
16:00 5.9 15:30 275 
18:45 12.08 18:15 505 








Figure 6: The BGC results when the insulin injection time is given from 30 minutes before to 30 minutes after each of the meal 
 
 
E. Effect of the Bodyweight to the BGC 
The weight of a person is normally stable over time as a 
result of the everyday food consumption and conducted 
activities [20]. Therefore, diabetes can be experienced either 
by a person with overweight or underweight [21]. As the 
patient undergo insulin therapy, he or she may result in 
weight gain as a factor to avoid hypoglycemia. An increase 
in body weight will result in increasing insulin dosing 
because the insulin dose may require more time to give effect 
to the blood glucose concentration as the insulin sensitivity 
decreasing [22].  
In other words, the sensitivity of the insulin to lower the 
blood glucose value will increase by the decrease in the body 
weight [23]. This trend can be seen in the results shown in 
Figure 7 which shows the superimposed graph from the BGC 
level of five different bodyweights which are 60 kg, 70 kg, 80 
kg, 90 kg and 100 kg. As the bodyweight is increasing, the 
body becomes less sensitive to the insulin effect and this 
causes the changes of blood glucose to a much lower value in 
the low body weight compared to the high bodyweight. Here, 
the insulin time has been set to 30 minutes before a meal 
where the insulin dose and CHO input are kept constant 




In conclusion, the development of the GUI for Hovorka 
Diabetic model based glucose-insulin analysis system has 
been successfully done by using MATLAB. Moreover, the 
result produced from this system of simulation-based analysis 
of glucose-insulin dynamics are comparable to several related 
previous studies [14-18]. For future recommendation, this 
system can be further developed for the analysis based on the 
model prediction control in the glucose-insulin dynamics. 
The system would attempt to analyze the regulation of the 
BGC for type 1 diabetes patient by manipulating the insulin 
infusion rate based on a certain control algorithm.  
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